Literature DB >> 7739661

In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.

A Arias1, M P Arévalo, A Andreu, C Rodríguez, A Sierra.   

Abstract

The in vitro susceptibility to amphotericin B, fluconazole, itraconazole and ketoconazole of 545 Candida strains from patients treated at the University Hospital of the Canaries was determined by means of a microdilution test. The distribution of the species was as follows: Candida albicans (342), Candida tropicalis (70), Candida glabrata (68), Candida parapsilosis (65). Of Candida albicans isolates, 8.5% and 7.6% showed resistance to itraconazole and fluconazole respectively. Of C. tropicalis isolates 34.3%, 27.1% and 2.9% were resistant to itraconazole, fluconazole and ketaconazole respectively. For C. glabrata, 10.3% and 4.4% of the isolates under study demonstrated resistance to fluconazole and itraconazole respectively. Only 4.6% and 1.5% of C. parapsilosis isolates demonstrated resistance to fluconazole and itraconazole respectively. C. tropicalis was the most resistant strain and C. parapsilosis the most sensitive. The greatest percentages of resistance in vitro were seen with the triazoles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7739661     DOI: 10.1111/j.1439-0507.1994.tb00428.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  New polyazole derivatives from 2-(2,4-dichlorophenyl)-1,3-dioxolane. Antifungal activity. Structure-activity relationships.

Authors:  A Delcourt; G Mathieu; H Baji; T Kimny; M Flammang; P L Compagnon
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 2.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

3.  In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis.

Authors:  Cristina Marcos-Arias; Elena Eraso; Lucila Madariaga; Alfonso Javier Carrillo-Muñoz; Guillermo Quindós
Journal:  Mycopathologia       Date:  2011-08-14       Impact factor: 2.574

Review 4.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 5.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Clinical itraconazole-resistant strains of Aspergillus fumigatus, isolated serially from a lung aspergilloma patient with pulmonary tuberculosis, can be detected with real-time PCR method.

Authors:  Hui Xu; Wei Chen; Lijuan Li; Zhe Wan; Ruoyu Li; Wei Liu
Journal:  Mycopathologia       Date:  2009-11-04       Impact factor: 2.574

7.  Isolation Frequency Characteristics of Candida Species from Clinical Specimens.

Authors:  Ga-Yeon Kim; Jae-Sik Jeon; Jae Kyung Kim
Journal:  Mycobiology       Date:  2016-06-30       Impact factor: 1.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.